Preface |
|
xvii | |
Acknowledgments |
|
xix | |
Chapter 1 Fundamental Concepts in Electromagnetics |
|
1 | |
|
|
1 | |
|
|
1 | |
|
|
2 | |
|
|
3 | |
|
1.2.3 Electromagnetic Fields |
|
|
6 | |
|
1.2.4 Electromagnetic Waves |
|
|
7 | |
|
1.3 Electromagnetic Induction |
|
|
10 | |
|
1.4 Electromagnetic Energy |
|
|
12 | |
|
1.5 Electromagnetic Spectrum |
|
|
12 | |
|
1.6 Sources of Electric and Magnetic Fields |
|
|
14 | |
|
|
14 | |
|
|
15 | |
|
1.6.1.2 Magnetic Resonance Imaging |
|
|
16 | |
|
1.6.1.3 DC Power Supply System |
|
|
16 | |
|
|
17 | |
|
1.6.2.1 Single-Conductor Source |
|
|
17 | |
|
1.6.2.2 Dual-Conductor Source |
|
|
18 | |
|
|
18 | |
|
1.6.2.4 Three-Phase Source |
|
|
19 | |
|
1.7 Sources of Radiofrequency Radiation |
|
|
19 | |
|
|
21 | |
|
|
21 | |
|
1.7.2.1 Transmission Lines |
|
|
21 | |
|
|
22 | |
|
|
22 | |
|
|
23 | |
|
1.7.3.1 Antenna Properties |
|
|
23 | |
|
1.7.3.2 Types of Antennas |
|
|
25 | |
|
|
27 | |
Chapter 2 Electromagnetic Interactions with Biological Systems |
|
29 | |
|
|
29 | |
|
2.2 Interaction Mechanisms |
|
|
30 | |
|
2.2.1 Mechanisms for Electric and Magnetic Fields |
|
|
30 | |
|
2.2.1.1 Induced Fields and Currents |
|
|
30 | |
|
|
31 | |
|
|
32 | |
|
2.2.1.4 Endogenous Fields |
|
|
32 | |
|
2.2.2 Mechanisms for Radio Frequency Radiation |
|
|
32 | |
|
2.2.2.1 Thermal Mechanisms |
|
|
32 | |
|
2.2.2.2 Nonthermal/Athermal Interaction Mechanisms |
|
|
33 | |
|
2.3 Electric Field Effects |
|
|
34 | |
|
2.3.1 Polarization of Bound Charges |
|
|
34 | |
|
2.3.2 Orientation of Permanent Electric Dipoles |
|
|
35 | |
|
2.3.3 Drift of Conduction Charges |
|
|
35 | |
|
2.3.4 Pearl-Chain Effects and Electrorotation |
|
|
35 | |
|
2.4 Magnetic Field Effects |
|
|
36 | |
|
|
36 | |
|
2.4.2 Magnetic Biosubstances |
|
|
37 | |
|
|
38 | |
|
2.4.4 Cell Membrane and the Chemical Link |
|
|
38 | |
|
2.4.5 Summary of ELF Interaction Mechanisms |
|
|
39 | |
|
2.5 Biological and Health Effects |
|
|
39 | |
|
2.5.1 Cells and Membranes |
|
|
39 | |
|
|
41 | |
|
2.5.3 Changes in Protein Conformation |
|
|
42 | |
|
2.5.4 Changes in Binding Probability |
|
|
42 | |
|
2.5.5 Absorption of Vibrational States of Biological Components |
|
|
43 | |
|
|
43 | |
|
|
44 | |
|
2.5.8 Hypothesis of Melatonin |
|
|
45 | |
|
|
46 | |
|
2.5.10 Brain and Nervous System. |
|
|
47 | |
|
|
48 | |
|
2.5.10.2 Physiological Effects |
|
|
49 | |
|
|
50 | |
|
2.6.1 Effect of Frequency |
|
|
50 | |
|
2.6.2 Low-Frequency Fields from Demodulation |
|
|
50 | |
|
|
51 | |
|
|
52 | |
PART I Health Risks of Electromagnetic Energy |
|
|
Chapter 3 Guidelines and Measurement for Hectic and Magnetic Fields |
|
|
59 | |
|
|
59 | |
|
|
60 | |
|
3.2.1 Institute of Electrical and Electronics Engineers |
|
|
61 | |
|
3.2.2 National Radiological Protection Board |
|
|
62 | |
|
3.2.3 International Commission on Nonionizing Radiation Protection |
|
|
62 | |
|
|
63 | |
|
|
63 | |
|
3.3 Measurement Techniques |
|
|
63 | |
|
3.3.1 Frequency and Object Size |
|
|
63 | |
|
3.3.2 Electric Field Measurements |
|
|
64 | |
|
3.3.3 Magnetic Field Measurements |
|
|
65 | |
|
|
66 | |
|
|
67 | |
|
3.4.1 Sources of EMF Exposure |
|
|
68 | |
|
3.4.1.1 Residential Areas |
|
|
68 | |
|
3.4.1.2 Power Lines and Cables |
|
|
68 | |
|
|
69 | |
|
3.4.3 Electric Appliances |
|
|
69 | |
|
|
72 | |
|
|
73 | |
|
3.6.1 Mitigation Techniques for Power Lines |
|
|
73 | |
|
3.6.1.1 Underground Cables |
|
|
73 | |
|
|
74 | |
|
3.6.1.3 Cancellation Techniques |
|
|
74 | |
|
3.6.2 Reducing the Level of ELF Exposure |
|
|
74 | |
|
3.6.3 Mitigation of Electric Fields |
|
|
75 | |
|
3.6.4 Mitigation of Magnetic Fields |
|
|
75 | |
|
3.6.4.1 Passive Shielding Techniques |
|
|
76 | |
|
3.6.4.2 Active Shielding Techniques |
|
|
77 | |
|
3.6.5 Protection from VDTs |
|
|
77 | |
|
|
78 | |
|
Chapter 4 Bioeffects of Electric and Magnetic Fields |
|
|
83 | |
|
|
83 | |
|
4.2 Epidemiological Studies |
|
|
83 | |
|
4.2.1 Public Environments |
|
|
84 | |
|
4.2.1.1 Childhood Cancer and Leukemia |
|
|
85 | |
|
|
86 | |
|
4.2.2 Occupational Environments |
|
|
87 | |
|
|
87 | |
|
4.2.2.2 Cardiovascular Diseases |
|
|
91 | |
|
4.2.2.3 Neurodegenerative Diseases |
|
|
91 | |
|
4.2.2.4 Reproductive Toxic Effects |
|
|
92 | |
|
4.2.3 Summary of Epidemiological Studies |
|
|
94 | |
|
4.3 Cellular and Animal Studies |
|
|
94 | |
|
4.3.1 Melatonin Hypothesis |
|
|
94 | |
|
4.3.2 Genotoxicity and Carcinogenicity |
|
|
95 | |
|
|
96 | |
|
4.3.3.1 Intracellular Calcium |
|
|
96 | |
|
4.3.3.2 Cell Proliferation |
|
|
96 | |
|
|
97 | |
|
4.3.3.4 Ornithine Decarboxylase (ODC) |
|
|
97 | |
|
|
97 | |
|
4.3.4 Animal Cancer Studies |
|
|
98 | |
|
4.3.5 Noncancer Animal Studies |
|
|
98 | |
|
4.3.5.1 Behavioral Effects |
|
|
98 | |
|
4.3.5.2 BloodBrain Barrier |
|
|
99 | |
|
4.3.5.3 Reproductive and Development |
|
|
99 | |
|
|
100 | |
|
4.4.1 Perception and Sensitivity |
|
|
100 | |
|
|
101 | |
|
4.4.3 Cardiovascular System |
|
|
102 | |
|
4.4.4 Melatonin in Humans |
|
|
102 | |
|
4.5 Concluding Remarks and Future Research |
|
|
103 | |
|
|
104 | |
|
|
105 | |
|
|
105 | |
|
Chapter 5 Radio Frequency Standards and Dosimetry |
|
|
119 | |
|
|
119 | |
|
5.2 RF Exposure Guidelines |
|
|
120 | |
|
|
120 | |
|
|
121 | |
|
5.2.2.1 IEEE Standard C95.1 |
|
|
121 | |
|
5.2.2.2 IEEE Standard 1528 |
|
|
122 | |
|
|
123 | |
|
|
124 | |
|
5.2.3.1 CENELEC EN 50392:2004 |
|
|
125 | |
|
5.2.3.2 EC Directive 2004/40/EC |
|
|
125 | |
|
|
127 | |
|
5.2.5 Incorporating Specific Absorption Rate |
|
|
127 | |
|
|
129 | |
|
5.3.1 Base Transceiver Stations |
|
|
130 | |
|
|
130 | |
|
|
131 | |
|
|
132 | |
|
5.3.3 Traffic Radar Devices |
|
|
132 | |
|
5.3.4 RF Heaters and Sealer, |
|
|
133 | |
|
|
133 | |
|
5.3.6 RF Environmental Levels |
|
|
133 | |
|
5.3.7 Magnetic Resonance Imaging and Spectroscopy Systems |
|
|
134 | |
|
5.4 Personal Safety Assessment |
|
|
134 | |
|
5.4.1 Whole-Body Phantoms |
|
|
134 | |
|
5.4.2 In-Head Assessments |
|
|
135 | |
|
|
136 | |
|
|
137 | |
|
5.4.2.3 Shielding for Mobile Antennas |
|
|
140 | |
|
|
140 | |
|
5.5.1 Harmonization of Safety Standards |
|
|
141 | |
|
5.5.2 Engineering Requirements and Dosimetric Information |
|
|
142 | |
|
|
143 | |
|
Chapter 6 Bioeffects and Health Implications of Radiofrequency Radiation |
|
|
149 | |
|
|
149 | |
|
6.2 Epidemiological Studies |
|
|
150 | |
|
6.2.1 Occupational Exposure Studies |
|
|
150 | |
|
6.2.1.1 Navy Personnel and Military Workers |
|
|
150 | |
|
6.2.1.2 Traffic Radar Devices |
|
|
151 | |
|
|
151 | |
|
6.2.1.4 Telecom Operators |
|
|
151 | |
|
6.2.2 Public Exposure Studies |
|
|
152 | |
|
6.2.2.1 Radio and TV Transmitters |
|
|
152 | |
|
6.2.2.2 Mobile and Cordless Phones |
|
|
152 | |
|
6.2.3 Summary of Epidemiological Studies |
|
|
156 | |
|
6.3 Cellular and Animal Studies |
|
|
156 | |
|
|
157 | |
|
|
158 | |
|
6.3.2.1 Cell Proliferation |
|
|
158 | |
|
6.3.2.2 Intracellular Calcium |
|
|
158 | |
|
6.3.2.3 Ornithine Decarboxylase |
|
|
158 | |
|
|
159 | |
|
6.3.4 Animal Cancer Experiments |
|
|
159 | |
|
6.3.5 Noncancer Animal Studies |
|
|
160 | |
|
6.3.5.1 Morphological and Physiological Effects |
|
|
160 | |
|
6.3.5.2 Testicular Function and Development |
|
|
160 | |
|
|
160 | |
|
6.3.5.4 Behavioral Effects |
|
|
160 | |
|
6.3.5.5 BloodBrain Barrier |
|
|
161 | |
|
|
161 | |
|
6.4.1 Perception and Auditory Response |
|
|
161 | |
|
6.4.2 Thermoregulatory Responses |
|
|
162 | |
|
|
163 | |
|
|
163 | |
|
6.4.5 Cardiovascular Diseases |
|
|
165 | |
|
|
165 | |
|
6.5 Concluding Remarks and Future Research |
|
|
165 | |
|
|
166 | |
|
|
167 | |
|
|
168 | |
|
Chapter 7 Electromagnetic Risk Analysis |
|
|
179 | |
|
|
179 | |
|
|
180 | |
|
7.2.1 Scientific Evidence |
|
|
180 | |
|
|
182 | |
|
7.2.3 Structured Risk Assessment |
|
|
183 | |
|
|
183 | |
|
7.3.1 Public Perception of Risk |
|
|
184 | |
|
7.3.2 Factors Relevant to Electromagnetic Fields |
|
|
184 | |
|
7.3.3 Health Consequences of Risk Perception |
|
|
185 | |
|
|
186 | |
|
7.4.1 Involving the Public |
|
|
186 | |
|
|
187 | |
|
7.4.3 Precautionary Approaches |
|
|
187 | |
|
7.4.4 Public Understanding of Precautionary Actions |
|
|
188 | |
|
|
188 | |
|
7.5.1 Role of Communication in Risk Assessment |
|
|
189 | |
|
7.5.2 Role of Communication in Risk Management |
|
|
189 | |
|
|
190 | |
|
|
191 | |
|
7.5.5 Role of the Internet |
|
|
191 | |
|
7.5.6 Communication with Children |
|
|
191 | |
|
7.6 Trends and Future Research |
|
|
192 | |
|
7.6.1 Challenges and Implications |
|
|
192 | |
|
7.6.2 Research and Policy |
|
|
193 | |
|
|
194 | |
|
|
194 | |
PART II Therapeutic Applications of Electromagnetic Energy |
|
|
Chapter 8 Electromagnetic Therapy |
|
|
199 | |
|
|
199 | |
|
8.2 History of Electromagnetic Therapy |
|
|
201 | |
|
8.3 Mechanism of Thermal injury |
|
|
202 | |
|
8.4 Thermal Therapy Treatment Protocol |
|
|
203 | |
|
8.5 Possible Side Effects of Electromagnetic Energy and Heat |
|
|
204 | |
|
8.5.1 Tissue Physiology and Response to Heat |
|
|
205 | |
|
|
206 | |
|
8.5.3 Immunological Effects |
|
|
207 | |
|
8.5.4 Cardiovascular Responses |
|
|
207 | |
|
8.5.5 Nervous System Responses |
|
|
208 | |
|
8.5.6 Carcinogenic Effects |
|
|
209 | |
|
|
210 | |
|
|
210 | |
|
8.6.2 Trends in Equipment Development |
|
|
211 | |
|
8.6.3 Future Research Directions |
|
|
212 | |
|
|
212 | |
|
Chapter 9 Electromagnetic Hyperthermia |
|
|
221 | |
|
|
221 | |
|
|
222 | |
|
|
223 | |
|
|
224 | |
|
|
224 | |
|
9.3 Types of Hyperthermia |
|
|
224 | |
|
|
225 | |
|
9.3.1.1 External Local Hyperthermia |
|
|
225 | |
|
9.3.1.2 Intraluminal Local Hyperthermia |
|
|
226 | |
|
9.3.1.3 Interstitial Local Hyperthermia |
|
|
227 | |
|
9.3.2 Regional Hyperthermia |
|
|
227 | |
|
9.3.2.1 Deep Regional Hyperthermia |
|
|
228 | |
|
9.3.2.2 Regional Perfusion Hyperthermia |
|
|
228 | |
|
9.3.2.3 Other Regional Hyperthermic Techniques |
|
|
229 | |
|
9.3.3 Whole-Body Hyperthermia |
|
|
229 | |
|
9.3.4 Extracellular Hyperthermia |
|
|
230 | |
|
9.4 Hyperthermia Heating Devices |
|
|
230 | |
|
|
231 | |
|
|
231 | |
|
|
231 | |
|
|
232 | |
|
9.4.2 External RF Applicators |
|
|
232 | |
|
9.4.2.1 Capacitive Heating |
|
|
232 | |
|
9.4.2.2 Inductive Heating |
|
|
233 | |
|
9.4.2.3 Hybrid Heating Systems |
|
|
234 | |
|
9.4.3 External Radiative EM Devices |
|
|
234 | |
|
9.4.3.1 Single Applicators |
|
|
235 | |
|
9.4.3.2 Multielement Array Applicators |
|
|
235 | |
|
9.4.4 Interstitial and Intracavitary Devices |
|
|
237 | |
|
9.4.5 Nanotechnology-Based Sources |
|
|
238 | |
|
9.5 Hyperthermia with Other Modalities |
|
|
240 | |
|
9.5.1 Hyperthermia and Radiation |
|
|
240 | |
|
9.5.2 Hyperthermia and Chemotherapy |
|
|
241 | |
|
9.5.3 Hyperthermia and Radiochemotherapy |
|
|
242 | |
|
9.5.4 Hyperthermia and Gene Therapy |
|
|
242 | |
|
|
243 | |
|
9.6.1 Biological and Physiological Mechanisms |
|
|
243 | |
|
9.6.2 Technical and Clinical Challenges |
|
|
243 | |
|
|
245 | |
|
|
245 | |
|
|
245 | |
|
Chapter 10 Radio Frequency and Microwave Ablation |
|
|
265 | |
|
|
265 | |
|
10.2 Thermal Ablation Therapy |
|
|
265 | |
|
10.2.1 Minimally Invasive Procedures |
|
|
266 | |
|
10.2.2 Ablation Techniques |
|
|
267 | |
|
10.2.3 Clinical Applications |
|
|
267 | |
|
|
268 | |
|
|
269 | |
|
|
269 | |
|
|
269 | |
|
|
270 | |
|
|
270 | |
|
10.2.3.7 Cardiac Diseases |
|
|
270 | |
|
|
271 | |
|
10.3.1 Technical Considerations |
|
|
271 | |
|
|
271 | |
|
10.3.1.2 Electrodes and Approaches |
|
|
272 | |
|
10.3.1.3 Multiple Applicators |
|
|
273 | |
|
|
274 | |
|
10.3.1.5 ThermalElectrical Modeling |
|
|
774 | |
|
10.3.2 Clinical Advantages and Applications |
|
|
275 | |
|
10.3.2.1 Cancer Treatment |
|
|
275 | |
|
10.3.2.2 Cardiac Diseases |
|
|
278 | |
|
10.3.2.3 Snoring and Obstructive Sleep Apnea (OSA) |
|
|
279 | |
|
|
280 | |
|
|
280 | |
|
|
282 | |
|
10.4.1 Technical Considerations |
|
|
282 | |
|
|
282 | |
|
|
283 | |
|
10.4. L3 Multiple Insertions and Multiple Antennas |
|
|
284 | |
|
10.4.2 Clinical Advantages and Applications |
|
|
285 | |
|
|
285 | |
|
10.4.2.2 Cardiac Diseases |
|
|
286 | |
|
10.4.2.3 Microwave Endometrial Ablation (MEA) |
|
|
288 | |
|
|
289 | |
|
|
290 | |
|
10.5 Trends and Future Research |
|
|
290 | |
|
10.5.1 Improved Techniques |
|
|
290 | |
|
10.5.2 Ablation in Clinical Practice |
|
|
291 | |
|
|
292 | |
|
|
293 | |
PART III Dosimetry and Imaging |
|
|
Chapter 11 Electromagnetic and Thermal Dosimetry |
|
|
311 | |
|
|
311 | |
|
11.2 EM Interaction with Biological Materials |
|
|
311 | |
|
11.3 Modeling Power Deposition |
|
|
314 | |
|
11.3.1 Techniques for Low Frequencies |
|
|
315 | |
|
11.3.2 Techniques for Radiofrequency Radiation |
|
|
315 | |
|
11.3.2.1 Analytical Techniques |
|
|
315 | |
|
11.3.2.2 Numerical Techniques |
|
|
315 | |
|
11.4 Specific Absorption Rate Modeling |
|
|
316 | |
|
|
317 | |
|
11.4.2 Thermal Measurements |
|
|
318 | |
|
|
319 | |
|
|
319 | |
|
11.5.1.1 Bioheat Equation |
|
|
320 | |
|
|
321 | |
|
11.5.1.3 Analysis Based on Pennes' Equation |
|
|
321 | |
|
|
322 | |
|
|
323 | |
|
11.5.4 WeinbaumJiji Model |
|
|
323 | |
|
|
324 | |
|
11.5.6 Applications of Bioheat Transfer Models |
|
|
324 | |
|
11.6 Thermal Therapy Planning System |
|
|
325 | |
|
11.6.1 Objectives and Requirements |
|
|
326 | |
|
11.6.2 Developments in TTPS |
|
|
327 | |
|
11.6.3 Thermal Monitoring |
|
|
327 | |
|
|
328 | |
|
|
328 | |
|
Chapter 12 Thermometry and Imaging |
|
|
337 | |
|
|
337 | |
|
12.2 Development of Thermometry |
|
|
338 | |
|
|
339 | |
|
12.3.1 Thermoelectric Thermometry |
|
|
339 | |
|
|
340 | |
|
12.3.3 Optical Fiber Thermometer |
|
|
341 | |
|
12.3.4 Applications and Comparison |
|
|
341 | |
|
12.4 Noninvasive Techniques |
|
|
342 | |
|
|
343 | |
|
|
343 | |
|
12.4.1.2 Advantages and Limitations |
|
|
344 | |
|
12.4.1.3 Two- to Three-Dimensional Ultrasonography |
|
|
344 | |
|
12.4.2 Magnetic Resonance Imaging |
|
|
345 | |
|
|
346 | |
|
|
347 | |
|
12.4.3 Microwave Radiometric Imaging |
|
|
347 | |
|
12.4.4 Terahertz Technology |
|
|
348 | |
|
12.4.4.1 Characteristics of THz Radiation |
|
|
349 | |
|
|
350 | |
|
|
351 | |
|
12.4.5 X-Ray Computed Tomography |
|
|
352 | |
|
12.4.5.1 Conventional CT Scanners |
|
|
352 | |
|
12.4.5.2 Spiral (Helical) CT Scanners |
|
|
352 | |
|
12.4.5.3 Multislice CT Scanners |
|
|
353 | |
|
|
353 | |
|
|
354 | |
|
|
355 | |
Acronyms and Abbreviations |
|
361 | |
Index |
|
365 | |